Founded Year



Series A - II | Alive

Total Raised


Last Raised

$20M | 2 mos ago

About EnsoData

EnsoData simplifies the process of reading and analyzing the human body to help quickly and accurately diagnose conditions, starting with sleep. Using artificial intelligence, its technology analyzes billions of data points collected from sensors placed throughout the entire human body to help clinicians quickly and consistently make diagnoses. Heartbeats on an EKG, eye movements through an EOG, and brain waves through an EEG all output as waveform data. The company is based in Madison, Wisconsin, and was founded in 2015.

EnsoData Headquarter Location

111 S Hamilton St Suite 30

Madison, Wisconsin, 53703,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

EnsoData's Products & Differentiation

See EnsoData's products and how their products differentiate from alternatives and competitors

  • EnsoSleep

    EnsoSleep is an AI scoring and analysis solution that automates event detection, providing consistent and reliable scoring of sleep studies, in a matter of minutes, ready for a clinician’s review.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Research containing EnsoData

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned EnsoData in 3 CB Insights research briefs, most recently on Aug 4, 2021.

Expert Collections containing EnsoData

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

EnsoData is included in 6 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

9,050 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Sleep Health & Wellness

800 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.


Medical Devices

11,584 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

13,068 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

7,900 items

Latest EnsoData News

🔒 Justin Mortara named president of EnsoData as company raises $20 million in funding

Jun 8, 2022

By Share Justin Mortara On the heels of Madison-based EnsoData announcing the completion of a $20 million Series A funding round, the company has also announced a noteworthy leadership change. Justin Mortara, the company’s executive chairman and an investor… Want to Read More? Paid BizTimes subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ . On the heels of Madison-based EnsoData announcing the completion of a $20 million Series A funding round, the company has also announced a noteworthy leadership change. Justin Mortara, the company’s executive chairman and an investor in the business, has also been named president. Mortara is also the co-founder of Milwaukee-based Rose Biosciences, a tech-focused bio startup, and principal at Mortara Group, LLC. He also spent over 20 years at Mortara Instrument, a provider of diagnostics for cardiovascular disease, as CEO. In February 2017, Mortara Instrument was acquired  by Chicago-based Hill-Rom Holdings Inc. for $330 million.In his new role as president, Mortara will support EnsoData's vision by preparing the company for scale in its next stage of growth. This includes expanding EnsoData's team, advancing its commercial strategy and identifying new strategic opportunities. Prior to this role, Mortara also managed a portfolio of early-stage health care investments spanning devices, tech-enabled services and life sciences.“As both a scientist and investor, I’ve reviewed a multitude of AI solutions in health care,” Mortara said. “The EnsoData team has created a truly unique platform in sleep that stands apart. With great initial customer traction and further AI-powered solutions under development, the time was right for me to assume a more active role and lend a hand in this exciting next chapter of growth.”EnsoData says its is the first AI technology cleared to aid clinicians in the diagnosis of sleep disorders and sleep apnea. The startup works primarily with clinicians, health systems and academic medical centers to improve health care outcomes by streamlining data analysis with waveform artificial intelligence.The company’s latest funding round was led by Inspire Medical Systems, Inc. of Golden Valley, Minnesota. Existing investors including Zetta Venture Partners, Venture Investors, Supermoon Capital, Colle Capital, HealthX Ventures, M25 Ventures and Mortara also took part in the funding round.EnsoData has experienced continued growth over the past year, driven by demand from customers seeking to enable faster and more accurate diagnoses and improve patient outcomes in the communities they serve.In the past year, EnsoData received its second FDA clearance, doubled its team in size, expanded partnerships with leading providers worldwide, and extended further support for virtual and at-home diagnostics.With this new funding, EnsoData will rapidly scale multinational expansion and commercial distribution partnerships, continue building out its team, and expand its product offerings.“Our proven, clinically validated technology has generated real demand and traction and as we continue to scale our team and growth,” said Chris Fernandez, CEO and co-founder of EnsoData. “With this confluence of new funding, new partnerships, and the addition of industry veterans like Justin to our team, we’re even better positioned today to continue our upward trajectory and to successfully navigate the evolving state of health care.” Sign Up Now Sign up for BizTimes Daily Alerts Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

EnsoData Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

EnsoData Rank

  • When was EnsoData founded?

    EnsoData was founded in 2015.

  • Where is EnsoData's headquarters?

    EnsoData's headquarters is located at 111 S Hamilton St, Madison.

  • What is EnsoData's latest funding round?

    EnsoData's latest funding round is Series A - II.

  • How much did EnsoData raise?

    EnsoData raised a total of $31.36M.

  • Who are the investors of EnsoData?

    Investors of EnsoData include HealthX Ventures, M25, Zetta Venture Partners, Colle Capital Partners, Venture Investors and 12 more.

  • Who are EnsoData's competitors?

    Competitors of EnsoData include Dozee, Itamar Medical, Philips Lifeline, Neurobit Technologies, Advanced Brain Monitoring and 7 more.

  • What products does EnsoData offer?

    EnsoData's products include EnsoSleep and 1 more.

  • Who are EnsoData's customers?

    Customers of EnsoData include CommonSpirit Health, Rush , MedBridge and BetterNight.

You May Also Like

BrightInsight Logo

BrightInsight provides a global platform for biopharma and MedTech regulated digital health solutions. The company helps accelerate time to market for apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD). BrightInsight offers configurable software modules and a proven platform built under a Quality Management System to support global security, privacy, and regulatory requirements. When building digital health products on the BrightInsight Platform, compliance is future-proofed as intended use changes scale across geographies.

Ultromics Logo

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

Clew Medical Logo
Clew Medical

Clew provides an AI-based analytics service and mobile app for the early detection of life-threatening complications in patients in intensive care units. The firm is developing versions of the products to extend to other aspects of healthcare.

TRIBVN Healthcare Logo
TRIBVN Healthcare

TRIBVN Healthcare supports the digital transformation of cancer diagnosis by designing innovative solutions. These solutions enable the management, analysis and sharing of cellular images for both diagnostic laboratories and pharmaceutical and biotech companies. The company offers customized support in digital pathology, focused on the customer’s expectations.

Biotwin Logo

Biotwin empowers health professionals with data-driven and technological solutions to help them make better decisions and recommendations

Neurobit Technologies Logo
Neurobit Technologies

Neurobit Technologies specializes in health data analytics with a focus on sleep and respiration. The company provides tools and knowledge to enable better understanding and control of sleep health and fitness.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.